GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Therma Bright Inc (TSXV:THRM) » Definitions » EPS (Diluted)

Therma Bright (TSXV:THRM) EPS (Diluted) : C$-0.01 (TTM As of Jul. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Therma Bright EPS (Diluted)?

Therma Bright's Earnings per Share (Diluted) for the three months ended in Jul. 2024 was C$-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jul. 2024 was C$-0.01.

Therma Bright's EPS (Basic) for the three months ended in Jul. 2024 was C$-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jul. 2024 was C$-0.01.

Therma Bright's EPS without NRI for the three months ended in Jul. 2024 was C$-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Jul. 2024 was C$-0.01.

During the past 3 years, the average EPS without NRIGrowth Rate was 46.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Therma Bright's highest 3-Year average EPS without NRI Growth Rate was 46.90% per year. The lowest was -58.70% per year. And the median was -3.60% per year.


Therma Bright EPS (Diluted) Historical Data

The historical data trend for Therma Bright's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Therma Bright EPS (Diluted) Chart

Therma Bright Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.04 -0.03 -0.02 -0.01

Therma Bright Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 - - - -0.01

Competitive Comparison of Therma Bright's EPS (Diluted)

For the Medical Devices subindustry, Therma Bright's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Therma Bright's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Therma Bright's PE Ratio distribution charts can be found below:

* The bar in red indicates where Therma Bright's PE Ratio falls into.



Therma Bright EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Therma Bright's Diluted EPS for the fiscal year that ended in Jul. 2024 is calculated as

Diluted EPS (A: Jul. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2.451-0)/318.242
=-0.01

Therma Bright's Diluted EPS for the quarter that ended in Jul. 2024 is calculated as

Diluted EPS (Q: Jul. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.872-0)/435.166
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Therma Bright  (TSXV:THRM) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Therma Bright EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Therma Bright's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Therma Bright Business Description

Traded in Other Exchanges
Address
345 Danforth Avenue, Toronto, ON, CAN, M4K 1N7
Therma Bright Inc is a developer and partner in a range of proprietary diagnostic and medical device technologies focused on providing consumers and medical professionals with solutions to address important medical and healthcare challenges. The Company is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on 3 key strategic areas: respiratory disease, vascular health, and consumer medical devices.
Executives
Joseph Ching-hiang Heng Director
Roberto Fia Director, Senior Officer
David J. Woods 10% Security Holder